NCT02642835

Brief Summary

Prolapse of the vaginal wall and uterus are common conditions affecting up to 50% of parous women. The socioeconomic, psychological and physical impacts of prolapse are considerable. 11% of women will undergo a surgical repair by the age of 80 years. The commonest compartment affected is the anterior vaginal wall. Unfortunately there is a significant rate of recurrent prolapse or a failure of the primary procedure. This has lead to the introduction of new techniques and the use of different materials to augment the repair. Mesh augmented repairs aim to reduce the rate of recurrent prolapse. However, the use of synthetic mesh is associated with complications which are not found in non mesh repairs. 10% of women will have a mesh complication of which 70% will require a further surgical procedure to manage the complication. There are extra costs associated with purchasing the mesh, with longer operating times to insert the mesh and managing complications caused by the mesh. Balancing the extra risks of mesh surgery against the benefits is probably one of the most contentious issues in urogynaecology at the present time. Regulatory authorities in the USA (FDA) and UK (MHRA) have become increasingly interested in the use of mesh to support the vaginal wall in prolapse surgery due to risks and complications being reported. To date there is little evidence regarding the long term safety and efficacy of anterior mesh repairs. This study aims to rectify this deficiency for Perigee.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

August 27, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 30, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

May 29, 2018

Completed
Last Updated

May 29, 2018

Status Verified

March 1, 2016

Enrollment Period

7 months

First QC Date

August 27, 2015

Results QC Date

March 30, 2017

Last Update Submit

September 17, 2017

Conditions

Keywords

meshpelvic organ prolapse

Outcome Measures

Primary Outcomes (1)

  • The Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted

    clinic visit. 5 patients were interviewed by phone and were not examined - hence this figure is out of 43 not 48.

    1 hour

Secondary Outcomes (9)

  • Number of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination

    1 hour

  • Number of Participants Complaining of a Bulge. Recurrent Prolapse

    1 hour

  • Number of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina

    1 hour

  • Number of Participants Who Underwent Reoperation for Prolapse in a Different Compartment

    1 hour

  • Number of Participants Who Developed New Stress Incontinence

    1 hour

  • +4 more secondary outcomes

Interventions

retrospective review of case series

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients having previously undergone a mesh repair

You may qualify if:

  • Women undergoing a perigee procedure after January 2007

You may not qualify if:

  • Patient having non mesh repairs over the same time scale

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medway NHS Foundation trust

Gillingham, Kent, ME5 7NY, United Kingdom

Location

MeSH Terms

Conditions

Genital Diseases, FemalePelvic Organ Prolapse

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Professor Jonaathan Duckett -Consultant Urogynaecologist
Organization
Medway NHS Foundation Trust

Study Officials

  • Jonathan Duckett, FRCOG

    Medway NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Urogynaecologist

Study Record Dates

First Submitted

August 27, 2015

First Posted

December 30, 2015

Study Start

August 1, 2015

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

May 29, 2018

Results First Posted

May 29, 2018

Record last verified: 2016-03

Locations